Detalles de la búsqueda
1.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560813
2.
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Br J Haematol
; 202(4): 776-784, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37386877
3.
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
J Med Virol
; 95(7): e28933, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403897
4.
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
Histopathology
; 81(6): 826-840, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109172
5.
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.
Ann Hematol
; 101(9): 2053-2067, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780254
6.
Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients.
BMC Infect Dis
; 22(1): 172, 2022 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35189833
7.
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative.
Ann Hematol
; 100(3): 825-830, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409623
8.
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.
Ann Hematol
; 99(4): 799-808, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32076827
9.
Epidemiologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study.
Biol Blood Marrow Transplant
; 24(3): 563-570, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29155041
10.
Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation.
Am J Transplant
; 18(12): 2885-2894, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603596
11.
Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors.
Br J Haematol
; 200(6): e58-e61, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652997
12.
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Blood
; 127(17): 2122-30, 2016 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26837699
13.
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 23(7): 1177-1185, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28396159
14.
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
Br J Haematol
; 178(5): 699-708, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28782811
15.
A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Transpl Infect Dis
; 19(4)2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544152
16.
Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib.
Br J Haematol
; 195(4): 637-641, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34402042
17.
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Br J Haematol
; 174(6): 859-67, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27185197
18.
Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome.
Blood
; 123(24): 3790-6, 2014 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24782504
19.
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.
Eur J Haematol
; 96(2): 128-35, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25845981
20.
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.
Blood
; 122(24): 3951-9, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24124086